Officials at U.S. General Mills Food Company stated that the U.S. food industry is not yet ready to accept genetically modified wheat because consumers are cautious about genetically modified products. Ron Olson, vice president of grain business at General Mills Foods, said that although wheat plantings in the United States continue to fall, the food industry is not accounting for wheat prices. He said that the United States can increase the import of Canadian spring wheat to meet domestic demand. Although biotechnology companies such as Monsanto and Swiss Syngenta have worked hard for many years, GM wheat is still stuck in promotion because consumers' resistance to genetically modified foods makes it difficult for food companies to accept such products. In 2004, Meng Shandu shelved the development of herbicide-resistant transgenic wheat. Swiss Syngenta has been studying low-key genetically modified spring wheat that is resistant to disease, but earlier this year it also stated that the company would not continue to promote GM wheat research and development projects without the support of major food companies. Olson said that Syngenta needs to prioritize enhancing wheat's nutrition or provide other features that cater to consumers' interests in order to overcome market resistance. Amber Sterile Serum Vials are primarily used for mixing different medications or solutions for injection or research applications like HCG, heparin, lidocaine, diabetic medications and morphine for intravenous or syringe injections. Finished vials can meet the FDA`s authorised 14-day sterility test.Amber Sterile Serum Vials are produced by aluminum caps, non-latex butyl stoppers and clear SCHOTT Neutral Type I glass vials. The production process of sterile Serum Vials is carried out under strict Class 100 workshop. Amber Sterile Serum Vials Amber Sterile Serum Glass Vials,Amber Serum Vials,Amber Glass Serum Vials China Lemon Trading Co.,Ltd , https://www.sterilevial.nl